Fahnestock & Shekari, (2019) found that pro-NGF levels were increased in the cortex and hippocampus regions of the brain in Alzheimer's disease due to cognitive impairment and neurodegeneration associated with this illness. The gene discussed is NGF; the disease is Alzheimer disease.